SureTrader Stock Hero Advertisement
Home > Boards > US OTC > Biotechs >

NanoLogix, Inc. (NNLX)

NNLX RSS Feed
Add NNLX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Emerald Isle
Search This Board:
Last Post: 4/27/2015 3:57:34 PM - Followers: 130 - Board type: Free - Posts Today: 0
 
 
ABOUT NANOLOGIX

Mission
Nanologix is a biotechnology company focused on rapid medical diagnostics. 
NanoLogix technology is used to design and market diagnostic test kits for use in early detection of bacteria and other microorganisms present in infectious and noninfectious human diseases, the environment, industrial and manufacturing settings, veterinary medicine, and research and testing laboratories. 
 
History
NanoLogix began 20 years ago under the name Infectech. The company has been issued 33 patents applicable in the areas of applied microbiology, soil microbiology, medical diagnostics, microbial physiology, molecular biology, pharmacology, pharmaco-kinetics, antibiotic sensitivity, stem-cell research, and hydrogen generation through use of bioreactors.
In 2007 the focus of the company evolved from pure Research and Development to capitalizing on the company's intellectual property through a transition to production of BNP™ and BNF™ Ultra-Fast diagnostic test kits and their marketing.     
 
Rapid Diagnostics and the BNP™

NanoLogix brings new velocity to the cutting edge field called "rapid diagnostics."  For that reason the company chose the term "Ultra-Fast" diagnostics for the BNP™. Other early detection devices in development at NanoLogix will bear the same designation.
 
Reduced testing time can save lives and money.

Nanologix Technology

NanoLogix technology provides live-cell rapid detection and identification dramatically faster than Flow Cytometry and traditional Petri culture methods. Additionally, in contrast to other fast methods such as Polymerase Chain Reaction (PCR), Nanologix technology does not require large investments in equipment or personnel training.

Based on advancements in Petri dish technology, the company's  Quick Test Kits, BioNanoPore (BNP™), and BioNanoFilter (BNF™) technologies are simple, easy to use and portable. The company states that the kits provide a more accurate, cost-effective alternative to PCR and Flow Cytometry.


Test Results  --  PARTIALLY UPDATED AS OF 01/31/2013-- FOR REFERENCE ONLY --

NanoLogix technology returns live-cell test results dramatically faster than Flow Cytometry and traditional Petri culture methods. Additionally, the technology is stated to be easy-to-use and does not require large investments in equipment or personnel training.

 

NANOLOGIX RAPID DETECTION TIMES for ACTIVE THREAT MICROORGANISMS

Comparison of BNP™ and BNF™ with traditional Petri dish technology.

 

 

 

          Microorganism BNP BNF

Traditional Time Range for Observance of Culture

Tuberculosis Mycobacterium tuberculosis
(ATCC 35801)

 
5 days* 1.5 hours*
 
21+ days
Vibrio cholerae (Cholera) 7 hours* <1 hour* 24+ hours
Yersinia pestis Yersinia pestis (bubonic plague) 24 hours* <1 hour* 48 hours
Bacillus anthracis Bacillus anthracis, (Anthrax) 6 hours* <1 hour* 24 hours
Group B Strep Group B Streptococcus (GBS) 4 hours <1 hour* 48 - 72 hours
Staphylococcus aureus Methicillin-resistant Staphylococcus aureus (MRSA) in process 6 hours* 18 - 24 hours
Burkholderia pseudomallei Burkholderia pseudomallei in process <1 hour* 18 - 24 hours
Brucella melitensis Brucella melitensis Brucella melitensis in process <1 hour* 18 - 24 hours
Escherichia coli Escherichia coli (E.coli) 0.5 hour 4 hours 18 - 24 hours
Salmonella Salmonella spp 0.5 hour 1 hour* 24 hours
Listeria ssp Listeria spp 5 hours in process 18 - 24 hours
Pseudomonas aeruginosa Pseudomonas aeruginosa 3 hours 5 hours 18 - 24 hours
Klebsiella pneumoniae Klebsiella pneumoniae 0.5 hour in process 24 hours
Endobacter cloacae Enterobacter cloacae 30 minutes 5 hours 24 hours
cryptosporidium Cryptosporidium in process <4 hours 14+ days
Streptococcus pyogenes 1 hour in process 18 - 24 hours
Gonorrhea pic Gonorrhea - <1 hour* 48 - 72 hours
cdiff pic Clostridium difficile  (C. Diff.) 4 hours* - 48 - 72 hours
  Assorted Yeasts  and Molds 12 -16 hours in process 48 - 72 hours


"NanoLogix Average" days/hours are based upon results achieved by NNLX through internal testing or results reported from independent third party tests. Detection time depends upon environmental conditions, sample quality, microorganism growth rates, nutrient concentrations, and many other factors. Actual results may vary.

 *External third-party results

 


The benefits of Ultra-Fast diagnostics are far-reaching:
 
·  Ultra-Fast diagnostics allow researchers in the lab to test for potentially pathogenic agents faster and develop effective countermeasures more rapidly and economically. This quality presents exciting opportunities in the pharmaceutical design process. 
  Can begin more effective drug treatment when an infectious disease is identified at an early stage. The spread of infectious disease may be reduced by earlier intervention. 
·In combat theaters and homeland security settings, the presence of specific pathogens can be detected closer to the epicenter of release. Site decontamination teams can identify surface samples closer to real time, potentially aiding the field process. 
 Industrial production - of food, beverage, drugs, or beauty products - can be paralyzed by microbial contamination.  The ripple effect may include expensive recalls, bad publicity, and government mandated "microbiology holds" that delay the replacement of product.  Ultra-Fast diagnostics can help minimize the impact by limiting the spread of spoiled product.
 
The BNP™ Ultra-Fast test kit is the first of NanoLogix's inventions to go to market. 
 
Advantages of BNP™
There are three main approaches to detection of microbes.  The conventional approach uses the Petri dish to culture samples in agar.  In general, this requires at least an 18 - 24 hour wait, in many instances much longer.
More recently, two other approaches have developed.  One is PCR (Polymerase Chain Reaction), and the other Flow Cytometry.
PCR technology detects the DNA of a cell.  Its shortcoming is the inability to distinguish between a live or dead cell.  It cannot be used for the determination of the actual threat posed by a potentially dangerous microorganism. The process utilizes complicated opto-electronics computerized instrumentation, with an equipment acquisition price of approximately $100,000.
Until NanoLogix's BNP™ appeared, Flow Cytomery was the standard for "fast" detection.  Though it can analyze one cell or particle in 1/10,000 of a second, it needs 18 hours (vs. 24 hours with the standard Petri dish) to provide accurate results.  It is also expensive and requires special equipment and technicians.
With the advent of BNP's™ technology, rapid diagnostics has just gained an important new tool.  
Based on Petri dish technology, the BNP™ provides a cheap, ultra-fast result in as little as one-third the time of the Flow Cytometry method, and one-quarter the time of the traditional Petri dish method.  It distinguishes between live and dead cells (a crucial requirement in identifying dangerous microbes.)  The technology is simple, easy to use, and portable.  It provides viewable cultures for evaluation far faster than any other method in use.
 
The BNP™
The BioNanoPore (BNP™) kit employs a membrane that is extremely thin, translucent, water permeable, and capable of working with organic and non-organic molecules and proteins. The membrane is non-permeable to cell structures, non-toxic for cells, hydrophilic, and non-fluorescent.  The BNP™ membrane is covered by a thin layer of solid nutrient media and can be used with nutrient agars of the type widely used in microbiological diagnostics.
 

APPLICATION

How the BioNanoPore (BNP™) Membrane Works

 

Simple to use:

Inoculate microorganisms on BNP™ Petri-based isolator plate 1.

After a rapid incubation period, generally a fraction of traditional incubation times, transfer the BNP™ membrane to BNP™ staining plate 2.

Within minutes, micro-colonies are visible on staining plate.

 
Market
The volume of Petri dishes used for traditional tests is millions per day worldwide. NanoLogix anticipates that the BNP™ Ultra-Fast technology will capture a portion of that market. 
According to Industrial Microbiology Market Review, worldwide industrial microbiology testing is undergoing tremendous growth. The same growth pattern is anticipated in the medical microbiological diagnostics market.
NanoLogix's potential customers are numerous and varied. They include microbiological laboratories in the industrial, medical, environmental, governmental (federal, state and local) sectors, research and development facilities, and educational institutions. 
 
R&D
NanoLogix's research and development continues on other diagnostic technology. The company's BNC™ technology utilizes a small disk with millions of nano-channels to trap microorganisms for analysis. Initial production of BNC™ kits will begin in late 2009. Extensive laboratory and field research was done from 2005-2008 on extraction of hydrogen gas from organic waste, with the data archived for potential future use.
 


*********************
PATENTS
*********************

The patent information link:
http://www.nanologix.com/index-4.html



*********************
SHARE STRUCTURE
*********************

 

Estimated Market Cap

  • $14,249,954 as of Jun 3, 2009

 

Outstanding Shares

         As of 1 April 2013, the company has 122,679,679 shares outstanding

         Authorized Shares         200,000,000 as of Dec 31, 2008
 

Number of Share Holders of Record

  • Over 3,000 shareholders as of early 2012.

        Float of 73,425,356 shares as of Dec 31, 2008



*************************
PRESS RELEASES
*************************

http://www.nanologix.com/news.htm


*******************
NNLX CHARTS
*******************

Price Quote:
http://www.investorshub.com/boards/quotes.asp?ticker=NNLX


( 1 month daily, 3 month daily, 1 year weekly)




________________________________________________________________________________________________________________________________

 

CONTACT

Corporate Headquarters

NanoLogix, Inc.

843 North Main Street
Hubbard, OH 44425 USA
330-534-0800 main line
330-534-0826 fax

E-mail: info@nanologix.com

Web site questions:

E-mail: webmaster@nanologix.com



ABOUT NANOLOGIX:
 

NANOLOGIX IS A BIOTECHNOLOGY COMPANY specializing in rapid diagnostics tools for biodefense, medical, environmental, and industrial uses.

The primary focus of NanoLogix is rapid detection of bacteria and other microorganisms.

The BNP™ ultra-fast test kit sets a new standard for accurate, high-speed diagnostics. With results two to four times faster than traditional Petri dish methods, NanoLogix technology represents a revolutionary next step in disease identification. 

Uses for NanoLogix's very-rapid diagnostics include biodefense, human and veterinary medicine, processing and safety of food, cosmetics and drugs, research and development, and industrial and environmental testing. Rapid detection of microorganisms is an annual multi-billion dollar market.

NanoLogix has been issued 33 patents in the areas of applied microbiology, soil microbiology and bioremediation, microbial physiology, molecular biology, pharmacology, pharmaco-kinetics, antibiotic sensitivity, stem-cell research, and bioreactor-based hydrogen generation. 



 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NNLX
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#8230  Sticky Note EVERYONE get your posts back on-topic. The IH Geek [Dave] 11/21/13 03:54:06 PM
#9098   Technically true but significant sales/interest in the product jshdan 04/24/15 04:45:51 PM
#9097   I looked at the past number of weeks Emerald Isle 04/24/15 10:35:18 AM
#9096   I would think I own a heck of pablo222 04/21/15 12:16:29 PM
#9095   The sales team consists of 1 man, the yman 04/01/15 12:35:56 PM
#9094   Your right, I was reading between the lines vinniefaz 03/30/15 11:24:29 AM
#9093   Vinniefaz, That's quite a reach to interpret someone's request Emerald Isle 03/29/15 05:25:45 PM
#9092   I believe that #9090 is suggesting when can vinniefaz 03/23/15 08:50:40 AM
#9091   Yman, I was told by another investor the company Emerald Isle 03/22/15 03:11:05 PM
#9090   Can anyone confirm we still have a sales yman 03/20/15 01:29:54 PM
#9089   This is an excellent update that all of Emerald Isle 03/01/15 06:03:44 PM
#9088   Then there's the N-Assay ELISA. That patent in Emerald Isle 02/17/15 07:50:11 PM
#9087   The flat pack packaging patent in China could Emerald Isle 02/17/15 06:25:10 PM
#9086   Based upon the information released by the company Emerald Isle 02/17/15 06:21:13 PM
#9085   The patent update is very significant. It will Emerald Isle 02/13/15 08:41:21 PM
#9084   Received from NanoLogix via email at 12:49PM: nanobuyer 02/11/15 02:14:21 PM
#9083  Restored One more thing with regard to the patent. shabby47 01/29/15 02:30:20 PM
#9082  Restored Go to the uspto pair site and search shabby47 01/28/15 10:42:31 AM
#9081  Restored Emerald, how did you find songbirdlive 01/28/15 09:25:32 AM
#9077   Emerald Isle 01/17/15 01:29:34 PM
#9076   Do some research on the USAMRIID Reston Virginia Emerald Isle 01/17/15 01:29:34 PM
#9075   This time probably but what about the next Abig 01/17/15 10:31:34 AM
#9074   The UN and its statements on the Ebola Emerald Isle 01/17/15 09:28:51 AM
#9073   What is your credentials, and your accompanying evidence, capitalismforever 01/17/15 05:30:01 AM
#9072   Capitalismforever, Four points to make in response: Emerald Isle 01/16/15 04:02:08 PM
#9071   Interesting post, especially considering that the same time capitalismforever 01/16/15 03:20:44 PM
#9070   N-Assay Notice of Patent Allowance mailed today. It Emerald Isle 01/16/15 12:18:44 PM
#9068   The Ebola update is great news. This is Emerald Isle 01/16/15 09:58:20 AM
#9067   Very cleverly written. Really has nothing to do capitalismforever 01/16/15 04:04:44 AM
#9066   NanoLogix is pleased to share the following information: ttboy 01/14/15 08:06:25 AM
#9065   This appears to be a new product listing Emerald Isle 01/09/15 10:16:56 AM
#9064   It was probably just a partial sell. Hotlead 01/07/15 08:03:21 AM
#9063   I too believe it possibly shows criminal activity capitalismforever 01/06/15 09:53:42 PM
#9062   In my opinion, anyone who traded 25 shares Emerald Isle 01/06/15 09:24:58 PM
#9061   "That wasn't the topic of my question" capitalismforever 01/06/15 02:48:16 PM
#9060   That wasn't the topic of my question but Emerald Isle 01/06/15 12:33:55 PM
#9059   It matters a lot. capitalismforever 01/06/15 12:15:47 PM
#9058   Why does where the inventors are matter? The Emerald Isle 01/02/15 02:35:42 PM
#9057   Saudi Arabia FRA approval shabby47 12/31/14 10:30:24 AM
#9056   Inventors: Barnhizer; Bret T.; (Poland, OH) ; Faro; Jonathan Abig 12/29/14 07:45:14 PM
#9055   I would think they will wait until the shabby47 12/29/14 04:45:55 PM
#9054   Appears the N-Assay patent has been allowed. Emerald Isle 12/29/14 10:24:40 AM
#9053   You're not allowed to have multiple aliases on capitalismforever 12/25/14 01:45:58 PM
#9052   The information about the cosmetic company came directly cars0nguy 12/23/14 08:43:06 PM
#9051   Emerald where did you get the info about Abig 12/23/14 07:46:41 PM
#9050   NanoLogix is pleased to release 2nd and 3rd Emerald Isle 12/23/14 07:18:36 PM
#9049   I made a breakdown of all the different shabby47 12/15/14 10:10:50 AM
#9048   I agree 100% with you. In addition, I capitalismforever 12/12/14 07:23:19 PM
#9047   The value of a company, what I call tedturnernot 12/12/14 06:03:39 PM
#9045   So you admit that you don't inder the shabby47 12/11/14 05:21:45 PM
#9044   "A logical person would also put some weight capitalismforever 12/11/14 04:53:17 PM
PostSubject